Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered polypeptides having enhanced duration of action and reduced immunogenicity

Engineered polypeptides having enhanced duration of action and reduced immunogenicity

US Patent 9879063 · Granted Jan 30, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Micro-nano impact indentation testing device and method based on cyclic refriger2025
ApoC-II mimetic peptides2023
Emollient topical disinfectants2023
Engineered polypeptides having enhanced duration of action2022
Engineered polypeptides having enhanced duration of action2022
Engineered polypeptides having enhanced duration of action2022
Engineered polypeptides having enhanced duration of action2022
Engineered polypeptides having enhanced duration of action2022
Polypeptides based on a scaffold2022
Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof2022
Systems, compositions and methods for treating diabetes2022
ApoC-II mimetic peptides2021